Apellis Pharmaceuticals, Inc. (APLS)
Latest APLS Insider Trades
Mark Jeffrey Delong - OfficerOpen-market sale$8K
A. Sinclair DunlopOther161,567 sh- A. Sinclair Dunlop
About Apellis Pharmaceuticals, Inc. (APLS)
Apellis Pharmaceuticals, Inc. is an SEC registrant, filing under CIK 0001492422, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
90-Day SEC Filing Activity
No Form 4 activity for APLS in the last 90 days.
APLS Insider Transactions (Form 4)
3289 Form 4 filings on record, the earliest from Nov 1, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Nur Nicholson - Officer | Grant or award | Common Stock |
Recent APLS Form 8-K Filings
4APLS Insider Trading - FAQ
What is the latest insider trade for APLS?
Apellis Pharmaceuticals, Inc. (APLS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-14. The full record for APLS runs to 89 Form 4 filings, the earliest from 2024-11-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying APLS stock?
No insider purchases of APLS were filed in the last 90 days.
How many insiders are selling APLS stock?
No insider sales of APLS were filed in the last 90 days. 47 sales are on record for this company.
Where can I see APLS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks APLS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow APLS insider buys?
Create a free InsiderAlpha account and press Watch on this page to add APLS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - A. Sinclair Dunlop view on EDGAR
- - James George Chopas view on EDGAR
- - Mikael Dolsten view on EDGAR
- - Leslie Meltzer view on EDGAR
- - Paul R. Fonteyne view on EDGAR
- - Timothy Eugene Sullivan view on EDGAR
- - Alec Machiels view on EDGAR
- - Pascal Deschatelets view on EDGAR
- - Gerald Chan view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where APLS's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track APLS insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
